The chart below shows the treatments the researchers planned to study:
Ceralasertib Ceralasertib and
by itself acalabrutinib
8 participants 3 participants
Ceralasertib tablets taken Acalabrutinib capsules alone,
either: twice a day for 4 weeks
• twice a day for up to
THEN
12 months
or • Acalabrutinib capsules
twice a day for up to
• twice a day for 2 weeks
12 months
on, then 2 weeks off, for
and
up to 12 months
• Ceralasertib tablets twice
a day for 1 week on, then
3 weeks off, for up to
12 months
After 12 months, the participants could continue to take their treatment until
their cancer got worse or they left the study for another reason.
6 | Clinical Study Results